KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,492,038 | -10.4% | 50,222 | +14.9% | 0.01% | 0.0% |
Q2 2023 | $9,477,646 | +6.1% | 43,706 | -11.1% | 0.01% | 0.0% |
Q1 2023 | $8,933,963 | -2.6% | 49,185 | +4.3% | 0.01% | -16.7% |
Q4 2022 | $9,176,921 | -9.1% | 47,142 | +4.9% | 0.01% | -14.3% |
Q3 2022 | $10,094,465 | +151.3% | 44,944 | +40.4% | 0.01% | +133.3% |
Q2 2022 | $4,016,360 | +5.7% | 32,006 | +4.5% | 0.00% | +50.0% |
Q1 2022 | $3,800,424 | +156.4% | 30,614 | +169.4% | 0.00% | +100.0% |
Q4 2021 | $1,482,000 | +5.6% | 11,363 | -1.0% | 0.00% | 0.0% |
Q3 2021 | $1,404,000 | -2.6% | 11,480 | -9.3% | 0.00% | 0.0% |
Q2 2021 | $1,442,000 | +30.9% | 12,654 | +38.0% | 0.00% | 0.0% |
Q1 2021 | $1,102,000 | +11.7% | 9,169 | -5.6% | 0.00% | 0.0% |
Q4 2020 | $987,000 | +35.4% | 9,712 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $729,000 | -27.2% | 9,431 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,002,000 | +106.2% | 9,431 | +39.7% | 0.00% | 0.0% |
Q1 2020 | $486,000 | – | 6,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |